Clinical trials for Systemic lupus erythematosus investigate a range of treatment strategies and patient populations.

67 total trials for this combination

Showing top 10 of 67 trials

Trials

NCT ID	Title	Status	Phase
NCT03616912	A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus	TERMINATED	PHASE3
NCT04186871	Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis	COMPLETED	PHASE2
NCT00410384	A Study of Belimumab in Subjects With Systemic Lupus Erythematosus	COMPLETED	PHASE3
NCT05843643	Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus	ACTIVE_NOT_RECRUITING	—
NCT01408576	Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus	COMPLETED	PHASE3
NCT03843125	A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)	TERMINATED	PHASE3
NCT01729455	Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) Registry	COMPLETED	—
NCT05843643	Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus	ACTIVE_NOT_RECRUITING	—
NCT01484496	A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)	COMPLETED	PHASE3
NCT04294667	A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus	COMPLETED	PHASE3

Related Pages

All Systemic lupus erythematosus trials All trials in Oklahoma City, United States